Safety and tolerability outcomes comprised discontinuation of treatment due to adverse events, incidence of serious adverse events, all-cause mortality, hypoglycaemia (plasma glucose 3.9 mmol/l), severe hypoglycaemia (a hypoglycaemic event requiring assistance), nausea, vomiting and diarrhoea
Innovators invested heavily in physician education and narrative-building generics entered assuming that groundwork would hold, but awareness at the grassroots level remains thin
Clinical studies have shown no major differences in clearance time across most patient groups with liver and kidney problems
(PubMed) Clarke R, Harrison G, Richards S
Our patients from Hurricane to Mesquite, NV frequently notice better energy, mood, and mobility within weeks